Clin2Atlas
AtlasInfectionsSexually transmitted infections excluding HIV

Genital herpes

2Disease-modifyingAI-generated
Burden-over-time charts — how many people this disease affects and whether that number is rising or falling — are coming to this page. The treatability read, milestones, and live trial pipeline below are current.

Milestones

dot size = significance
199020002010202020251994 — Famciclovir approved (FDA)1995 — Valacyclovir approved (FDA)
1994: Drug approval — Famciclovir approved (FDA). 1995: Drug approval — Valacyclovir approved (FDA)

What's being tested now

2013: 1 trials started2023: 1 trials started2025: 1 trials started202020251

Trials started per year, stacked by phase (darker = later phase). Source: ClinicalTrials.gov via Clin2, which tracks studies recruiting in recent years — early years undercount.

Related

SyphilisChlamydial infectionGonococcal infectionTrichomoniasisOther sexually transmitted infections

Burden estimates: IHME Global Burden of Disease Study. Drug indications: ChEMBL (CC BY-SA). Trial data: ClinicalTrials.gov via Clin2. Velocity, acceleration, and turning points are computed by Clin2 — how this page is made. Treatability describes what medicine can do, not what is available everywhere. This page describes populations, not people, and is not medical advice.